245 related articles for article (PubMed ID: 19877631)
1. Small molecule modulators of copper-induced Abeta aggregation.
Hindo SS; Mancino AM; Braymer JJ; Liu Y; Vivekanandan S; Ramamoorthy A; Lim MH
J Am Chem Soc; 2009 Nov; 131(46):16663-5. PubMed ID: 19877631
[TBL] [Abstract][Full Text] [Related]
2. Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity.
Choi JS; Braymer JJ; Nanga RP; Ramamoorthy A; Lim MH
Proc Natl Acad Sci U S A; 2010 Dec; 107(51):21990-5. PubMed ID: 21131570
[TBL] [Abstract][Full Text] [Related]
3. Development of bifunctional stilbene derivatives for targeting and modulating metal-amyloid-β species.
Braymer JJ; Choi JS; DeToma AS; Wang C; Nam K; Kampf JW; Ramamoorthy A; Lim MH
Inorg Chem; 2011 Nov; 50(21):10724-34. PubMed ID: 21954910
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation.
Choi JS; Braymer JJ; Park SK; Mustafa S; Chae J; Lim MH
Metallomics; 2011 Mar; 3(3):284-91. PubMed ID: 21210061
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
Peng YB; Tao C; Tan CP; Zhao P
J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
[TBL] [Abstract][Full Text] [Related]
6. Azo-Stilbene and Pyridine-Amine Hybrid Multifunctional Molecules to Target Metal-Mediated Neurotoxicity and Amyloid-β Aggregation in Alzheimer's Disease.
Rana M; Cho HJ; Arya H; Bhatt TK; Bhar K; Bhatt S; Mirica LM; Sharma AK
Inorg Chem; 2022 Jul; 61(27):10294-10309. PubMed ID: 35768324
[TBL] [Abstract][Full Text] [Related]
7. Copper-mediated β-amyloid toxicity and its chelation therapy in Alzheimer's disease.
Singh SK; Balendra V; Obaid AA; Esposto J; Tikhonova MA; Gautam NK; Poeggeler B
Metallomics; 2022 Jun; 14(6):. PubMed ID: 35333348
[TBL] [Abstract][Full Text] [Related]
8. Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1-3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu(2.).
Dong M; Li H; Hu D; Zhao W; Zhu X; Ai H
ACS Chem Neurosci; 2016 May; 7(5):599-614. PubMed ID: 26871000
[TBL] [Abstract][Full Text] [Related]
9. Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo.
Yu D; Guan Y; Bai F; Du Z; Gao N; Ren J; Qu X
Chemistry; 2019 Mar; 25(14):3489-3495. PubMed ID: 30601592
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
11. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
Mancino AM; Hindo SS; Kochi A; Lim MH
Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
[TBL] [Abstract][Full Text] [Related]
12. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.
Summers KL; Roseman G; Schilling KM; Dolgova NV; Pushie MJ; Sokaras D; Kroll T; Harris HH; Millhauser GL; Pickering IJ; George GN
Inorg Chem; 2022 Sep; 61(37):14626-14640. PubMed ID: 36073854
[TBL] [Abstract][Full Text] [Related]
14. Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
Lakey-Beitia J; Burillo AM; La Penna G; Hegde ML; Rao KS
J Alzheimers Dis; 2021; 82(s1):S335-S357. PubMed ID: 32568200
[TBL] [Abstract][Full Text] [Related]
15. The impact of chelating compounds on Cu
Mazur T; Malik M; Bieńko DC
J Inorg Biochem; 2024 Aug; 257():112601. PubMed ID: 38744143
[TBL] [Abstract][Full Text] [Related]
16. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors.
Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B
Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379
[TBL] [Abstract][Full Text] [Related]
17. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron.
Tahmasebinia F; Emadi S
Biometals; 2017 Apr; 30(2):285-293. PubMed ID: 28281098
[TBL] [Abstract][Full Text] [Related]
18. Disaggregation ability of different chelating molecules on copper ion-triggered amyloid fibers.
Zhu L; Han Y; He C; Huang X; Wang Y
J Phys Chem B; 2014 Aug; 118(31):9298-305. PubMed ID: 25051063
[TBL] [Abstract][Full Text] [Related]
19. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
Faller P; Hureau C; La Penna G
Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
[TBL] [Abstract][Full Text] [Related]
20. How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.
Conte-Daban A; Day A; Faller P; Hureau C
Dalton Trans; 2016 Oct; 45(39):15671-15678. PubMed ID: 27711738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
